Indeed, ROS can induce skin carcinogenesis, but higher doses lead to cell death/apoptosis; the antioxidant Nrf2, traditionally considered a tumor suppressor for its cytoprotective functions, is activated during tumor progression, and its content is higher in chemo-resistant cells [168,169,170]. The gene discussed is NFE2L2; the disease is neoplasm.